Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:969-970 (3 May), doi:10.1136/bmj.39553.408924.80 (published 23 April 2008)
Avoid corticosteroids for prophylaxis; possibly use them for treatment
| The first 150 words of the full text of this article appear below. |
Acute respiratory distress syndrome (ARDS) is a major health problem, with the annual incidence in the United States approaching 200 000 cases.1 In the accompanying paper, Peter and colleagues present a systematic review and meta-analysis of nine randomised controlled trials (1073 patients) of corticosteroids for prevention and treatment of ARDS.2 ARDS is a form of severe respiratory failure resulting from direct pulmonary insults (for example, aspiration or pneumonia) or indirect systemic causes (for example, sepsis or trauma).3 This syndrome often has devastating consequences, such as the prolonged need for mechanical ventilation, a high probability of death, and long term physical and psychological sequelae in survivors. Treatment is unlikely to be successful in least developed countries because of limited critical care resources.4
No effective drug treatments are available for ARDS,5 but corticosteroids have attracted attention because they have anti-inflammatory properties that are relevant to ARDS pathology. They reduce both leakage of
Neill K J Adhikari, lecturer, Damon C Scales, assistant professor
1 Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada M4N 3M5
neill.adhikari@utoronto.ca
what's wrong with significance tests? Another comment on the role of statistical methods
What can you learn from this BMJ paper? Read Leanne Tite's Paper+